Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florian Rensch

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 18, 2008
Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusionFlorian Rensch, Jost B Jonas, Ulrich H M Spandau
Acta Ophthalmologica|October 22, 2008
Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusionFlorian Rensch, Jost B Jonas, Ulrich H M Spandau
Acta Ophthalmologica|February 13, 2009
Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonideFlorian Rensch, Ulrich H M Spandau, Anne Wickenhäuser, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 27, 2007
Infectious and noninfectious endophthalmitis after intravitreal bevacizumabJost B Jonas, Ulrich H Spandau, Florian Rensch, et al.
Plos One|May 26, 2012
Optic nerve head change in non-arteritic anterior ischemic optic neuropathy and its influence on visual outcomeJost B Jonas, Sohan Singh Hayreh, Yong Tao, et al.
The Journal of Urology|June 18, 2004
Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1)Lutz Trojan, Maurice Stephan Michel, Florian Rensch, et al.
Acta Ophthalmologica|May 13, 2009
Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degenerationJost B Jonas, Teodosio Libondi, Lidia Golubkina, et al.
Investigative Ophthalmology & Visual Science|July 7, 2009
Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopyFrank C Schlichtenbrede, Wolfgang Mittmann, Florian Rensch, et al.
BJU International|September 19, 2006
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancerLutz Trojan, Florian Rensch, Martin Voss, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|June 18, 2008
Intravitreal bevacizumab for myopic choroidal neovascularizationFlorian Rensch, Ulrich H M Spandau, Frank Schlichtenbrede, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|December 18, 2008
Early intravitreal bevacizumab for non-ischaemic branch retinal vein occlusionFlorian Rensch, Jost B Jonas, Ulrich H M Spandau
Acta Ophthalmologica|October 22, 2008
Early intravitreal bevacizumab for non-ischaemic central retinal vein occlusionFlorian Rensch, Jost B Jonas, Ulrich H M Spandau
Acta Ophthalmologica|February 13, 2009
Diffuse diabetic macular oedema treated with intravitreal bevacizumab or triamcinolone acetonideFlorian Rensch, Ulrich H M Spandau, Anne Wickenhäuser, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|June 27, 2007
Infectious and noninfectious endophthalmitis after intravitreal bevacizumabJost B Jonas, Ulrich H Spandau, Florian Rensch, et al.
Plos One|May 26, 2012
Optic nerve head change in non-arteritic anterior ischemic optic neuropathy and its influence on visual outcomeJost B Jonas, Sohan Singh Hayreh, Yong Tao, et al.
The Journal of Urology|June 18, 2004
Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1)Lutz Trojan, Maurice Stephan Michel, Florian Rensch, et al.
Acta Ophthalmologica|May 13, 2009
Combined intravitreal bevacizumab and triamcinolone in exudative age-related macular degenerationJost B Jonas, Teodosio Libondi, Lidia Golubkina, et al.
Investigative Ophthalmology & Visual Science|July 7, 2009
Toxicity assessment of intravitreal triamcinolone and bevacizumab in a retinal explant mouse model using two-photon microscopyFrank C Schlichtenbrede, Wolfgang Mittmann, Florian Rensch, et al.
BJU International|September 19, 2006
The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancerLutz Trojan, Florian Rensch, Martin Voss, et al.
Ophthalmic Surgery, Lasers & Imaging : the Official Journal of the International Society for Imaging in the Eye|June 18, 2008
Intravitreal bevacizumab for myopic choroidal neovascularizationFlorian Rensch, Ulrich H M Spandau, Frank Schlichtenbrede, et al.
Pageof 3